VeriMomHamilelikte lithium hydroxide kullanmaktan kaçınmalı mıyım? | VeriMom
ECHA/RAC has proposed harmonised classification for lithium hydroxide as reproductive toxicant (Repr. 1A, H360—may damage fertility/unborn child) and lactation (H362); regulatory bodies and risk assessments driving that proposal cite mammalian data and human lithium drug literature showing placental transfer and developmental effects. This supports a confirmed hazard (H360 → h=3) and a demonstrated mechanism (placental transfer / developmental signalling effects from lithium). Topical cosmetic exposure would give low but measurable systemic exposure in normal use (hence e=1). (Sources: ECHA registry and RAC/ANSES material; PubMed reviews on lithium exposure in pregnancy).
ECHA regulatory hazard statements
- •H360
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- lithium hydroxide hamilelikte güvenli mi?
- ECHA/RAC has proposed harmonised classification for lithium hydroxide as reproductive toxicant (Repr. 1A, H360—may damage fertility/unborn child) and lactation (H362); regulatory bodies and risk assessments driving that proposal cite mammalian data and human lithium drug literature showing placental transfer and developmental effects. This supports a confirmed hazard (H360 → h=3) and a demonstrated mechanism (placental transfer / developmental signalling effects from lithium). Topical cosmetic exposure would give low but measurable systemic exposure in normal use (hence e=1). (Sources: ECHA registry and RAC/ANSES material; PubMed reviews on lithium exposure in pregnancy).
- lithium hydroxide emzirirken güvenli mi?
- RAC/ANSES proposals include a lactation hazard (H362) for lithium salts; clinical/literature on therapeutic lithium shows transfer into breastmilk and effects on breastfed infants, supporting a confirmed hazard (h=3) and demonstrated mechanism (maternal→milk transfer). Topical cosmetic use is expected to give low but measurable maternal systemic exposure (e=1) unless formulations/uses provide negligible absorption. (Sources: ECHA/ANSES/RAC documentation; PubMed clinical reviews on lithium and breastfeeding).
- lithium hydroxide bebek cildi için güvenli mi?
- Hazard and mechanism remain driven by the same lithium salt evidence (RAC proposal Repr.1A/H360 and lactation H362; systemic lithium crosses placenta and is secreted in milk). Because infant skin (0–3 yr) has higher surface-area-to-weight and a less mature barrier, exposure score is increased by +1 (adult e=1 → infant e=2). There is no infant-specific evidence changing hazard or mechanism, but increased dermal exposure potential supports higher exposure concern for babies. (Sources: ECHA/ANSES/RAC; PubMed literature on lithium transfer and infant effects; CosIng listing and restriction notes).
- VeriMom lithium hydroxide nasıl puanlıyor?
- VeriMom lithium hydroxide'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 20/100 (yüksek risk) olarak puanlar.
- Hamilelikte lithium hydroxide yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.